Victrex plc (LON:VCT) Receives Average Rating of “Hold” from Brokerages

Victrex plc (LON:VCT) has earned an average recommendation of “Hold” from the six ratings firms that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating on the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is GBX 663.33.

Several research firms have issued reports on VCT. Berenberg Bank increased their price objective on Victrex from GBX 600 to GBX 680 and gave the stock a “hold” rating in a research note on Wednesday, July 8th. Jefferies Financial Group restated a “hold” rating and issued a GBX 595 target price on shares of Victrex in a research note on Tuesday, July 7th. Canaccord Genuity Group lowered shares of Victrex to a “buy” rating and set a GBX 725 target price on the stock. in a report on Friday, May 15th. Finally, UBS Group reiterated a “sell” rating and set a GBX 575 target price on shares of Victrex in a research report on Monday, May 11th.

Victrex Trading Up 1.0%

VCT stock opened at GBX 787.45 on Friday. Victrex has a 1-year low of GBX 515 and a 1-year high of GBX 819. The company has a current ratio of 2.35, a quick ratio of 1.99 and a debt-to-equity ratio of 21.30. The business’s 50 day moving average is GBX 655.03 and its 200-day moving average is GBX 645.44. The firm has a market cap of £686.06 million, a P/E ratio of -35.15, a P/E/G ratio of 1.92 and a beta of 0.77.

Victrex (LON:VCT) last posted its earnings results on Monday, May 11th. The company reported GBX 17.20 EPS for the quarter. The business had revenue of £147.10 million during the quarter. Victrex had a negative return on equity of 4.95% and a negative net margin of 6.70%. Equities analysts anticipate that Victrex will post 73.1078905 earnings per share for the current fiscal year.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.